Preterm Labor Clinical Trial
Official title:
Nifedipine Pharmacokinetics and Pharmacodynamics When Used as a Tocolytic in Patients Hospitalized for Acute Threatened Preterm Labour
Preterm birth is the leading cause of perinatal mortality and morbidity. According to WHO,
15 million children are born prematurely (gestational age < 37 weeks) in the world each year
while 7% of them die because of complications associated with prematurity. Despite constant
improvement of obstetrical care, the number of preterm births has increased over the last
decades and prematurity is still the most frequent cause of prenatal hospitalization in
industrialized countries.
The American College of Obstetricians and Gynecologists as well as the Royal College of
Obstetricians and Gynaecologists recommend nifedipine as a first-line tocolytic in case of
acute threatened preterm labour. Clinical experience show however an important variability
in treatment response among pregnant women. In spite of its large use in obstetrics as a
tocolytic agent, nifedipine is prescribed off-label. As a consequence no international
consensus on optimal dose schedule has so far been proposed.
Small sample size and heterogeneousness of tocolysis administration protocols make it
difficult to compare the little data available on the pharmacokinetics of nifedipine in
pregnant women. Nevertheless an important interindividual variability in concentrations has
been identified (CV=12-76%) but very few studies have investigated the possible reasons of
this variability in pregnant women. Genetic and environmental factors involved in drug
distribution and metabolism (e.g. enzymatic activity, CYP 3A5 genotype) might partially
explain variability in drug levels and therefore differences in treatment response.
The goal of this study is to quantify the variability in nifedipine pharmacokinetics and
identify potential genetic and non-genetic sources of variability in nifedipine
pharmacokinetics in pregnant women. The relationship between concentration and treatment
response will be evaluated and will serve to propose optimal dosage regimen to improve
efficacy and reduce side effects associated with this treatment.
n/a
Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06168149 -
The Relationship of Fetal Lung Elastography Values With the Development of Respiratory Distress in Cases of Preterm Labor
|
||
| Completed |
NCT02538718 -
Efficacy and Safety of MgSO4 as Tocolytics Compared to Ritodrine in Preterm Labor
|
N/A | |
| Not yet recruiting |
NCT05864066 -
Cyclin-dependent Kinase Inhibitor 2A (Placental Senescence Marker) on Labor-related Signals
|
||
| Terminated |
NCT03715530 -
Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women
|
N/A | |
| Recruiting |
NCT03638037 -
Correlation Between Maternal Vitamin D Level And Preterm Birth
|
||
| Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
| Completed |
NCT02536352 -
Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being
|
Early Phase 1 | |
| Withdrawn |
NCT03122704 -
Group B Streptococcus (GBS) Infection and in Preterm Labor Women Conceived Through IVF
|
N/A | |
| Recruiting |
NCT01518816 -
Role of Serum Total Antioxidant Level in Preterm Labor
|
N/A | |
| Recruiting |
NCT04590677 -
Prediction of the Onset of Term and Preterm Labour
|
||
| Completed |
NCT03112018 -
Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda
|
N/A | |
| Active, not recruiting |
NCT04301518 -
Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs
|
N/A | |
| Completed |
NCT03785795 -
Multichannel EMG Diagnosing True Preterm Labor
|
||
| Withdrawn |
NCT02351310 -
Effectiveness of ACS in Extreme Preemies
|
Phase 3 | |
| Not yet recruiting |
NCT01985594 -
Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial
|
Phase 2 | |
| Not yet recruiting |
NCT04532086 -
Uterocervical Angle and Preterm Labour
|
||
| Completed |
NCT04605172 -
Lockdown Impact on Spontaneous Premature Birth in a Level III NICU
|
||
| Recruiting |
NCT04417595 -
Investigating N-3 Fatty Acids to Prevent Neonatal Tobacco-related outcomeS
|
Phase 2 | |
| Completed |
NCT03923023 -
Impact of the PREEMI Package on Neonatal Mortality
|
||
| Recruiting |
NCT06157203 -
Labor Status Monitor for Diagnosing True vs False Labor in Preterm Patients
|